Healthy infants and toddlers will receive MenACYW conjugate vaccine or a licensed meningococcal vaccine, and routine pediatric vaccines.
All participants will be assessed for immunogenicity before and after vaccination.
Safety will be assessed throughout the study period, and includes solicited injection site and systemic reactions as well as unsolicited adverse events after each vaccine injection, and serious adverse events occurring throughout the study.
How understandable was the trial content above?
Hard to understand
Easy to understand
